Consistent Results Observed With Topical Roflumilast in Second Atopic Dermatitis Trial
The INTEGUMENT-2 trial included patients 6 years of age and older with mild to moderate atopic dermatitis involving at least 3% body surface area.
Diagnosis & Disease Information
Studies Show Bimekizumab Benefits Patients With Hidradenitis Suppurativa
The BE HEARD I and BE HEARD II studies included more than 1000 adults with moderate to severe hidradenitis suppurativa.
Delgocitinib Cream Significantly Improves Chronic Hand Eczema in Trial
The trial met its primary endpoint with a significantly larger proportion of delgocitnib-treated patients achieving treatment success.
FDA Approves Sotyktu for Moderate to Severe Plaque Psoriasis
The approval was based on data from the phase 3 POETYK PSO-1 and POETYK PSO-2 trials in adults with moderate to severe plaque psoriasis.
Topical Gene Therapy Gets Priority Review for Dystrophic Epidermolysis Bullosa
B-VEC is an investigational topical gene therapy designed to deliver 2 copies of the COL7A1 gene when applied directly to DEB wounds.
Companies Selling Unapproved Drugs for Mole, Skin Tag Removal Get FDA Warning Letter
The Companies are in violation of the FD&C Act, as these products are being marketed with unauthorized claims to remove lesions, including moles and skin tags.
FDA to Review Resubmitted Application for Severe Burn Therapy NexoBrid
NexoBrid is a topically administered, bromelain-based biological product containing a sterile mixture of proteolytic enzymes.
Study Investigating Oral JAK Inhibitor for Alopecia Areata Meets Endpoint
CTP-543 is an investigational oral selective inhibitor of JAK1 and JAK2.
Zoryve Cream Approved for Plaque Psoriasis
The approval was based on data from the two phase 3 trials that included patients aged 12 years and older with mild to severe plaque psoriasis.
Opzelura Cream Approved for Nonsegmental Vitiligo
The approval was based on data from two phase 3 studies, which included patients 12 years of age and older with nonsegmental vitiligo who had depigmented areas.
- Loading...
Loading...
Next post in Dermatology
Loading... 
Loading...